Related Experiment Videos
[Diagnostic image (19). Ecthyma gangraenosum].
1Academisch Ziekenhuis, afd. Inwendige Geneeskunde, Postbus 9101, 6500 HB Nijmegen.
Nederlands Tijdschrift Voor Geneeskunde
|February 24, 2001
Summary
A man undergoing chemotherapy for acute myeloid leukaemia developed ecthyma gangraenosum caused by Pseudomonas aeruginosa. Prompt antibiotic treatment and granulocyte normalization led to his full recovery.
Area of Science:
- Hematology
- Infectious Diseases
- Dermatology
Background:
- Acute myeloid leukaemia (AML) is a hematologic malignancy requiring intensive chemotherapy.
- Chemotherapy can lead to neutropenia, increasing susceptibility to infections.
- Pseudomonas aeruginosa is an opportunistic pathogen, particularly in immunocompromised individuals.
Observation:
- A 30-year-old male patient with AML developed characteristic skin lesions during chemotherapy.
- Cultures of blood and skin lesions identified Pseudomonas aeruginosa as the causative agent.
- The clinical presentation was consistent with ecthyma gangraenosum.
Findings:
- Ecthyma gangraenosum is a severe cutaneous infection caused by Pseudomonas aeruginosa.
- The patient's skin lesions and bloodstream infection were successfully treated with targeted antibiotics.
- Normalization of granulocyte counts was crucial for patient recovery.
Implications:
- This case highlights the importance of recognizing ecthyma gangraenosum in immunocompromised patients.
- Early diagnosis and appropriate antimicrobial therapy are critical for managing Pseudomonas aeruginosa infections in AML patients.
- Effective management can lead to complete recovery, even in severe cases.